HALO — Halozyme Therapeutics Share News
0.000.00%
Last trade - 00:00- $13.79bn
- $15.71bn
- $1.40bn
Brief: Halozyme Therapeutics Q4 Operating Expenses USD 122.507 Million
U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar
Brief: Halozyme Reiterates 2024 Financial Guidance And Raises 2025 And Multi-Year Financial Guidance
US FDA approves injectable form of Bristol Myers' Opdivo (updated)
US FDA approves injectable form of Bristol Myers' Opdivo
U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity
U.S. STOCKS ON THE MOVE-CC Holding, CBRE, Lexicon Pharmaceuticals
U.S. STOCKS ON THE MOVE-Jet.AI, SL Green, WTW
Brief: Evotec Has Taken Notice Of Statement Made By Halozyme Therapeutics Inc.
Deals of the day-Mergers and acquisitions
Halozyme gains after withdrawing $2.1 bln buyout offer for Evotec
Brief: Halozyme Withdraws Proposal To Acquire Evotec Following Evotec's Unwillingness To Engage In Discussions
Halozyme withdraws $2.1 bln buyout offer for Evotec (updated)
Evotec slumps as Halozyme withdraws buyout offer
Brief: Halozyme Withdraws Proposal To Acquire Evotec Following Evotec's Unwillingness To Engage In Discussions
Halozyme withdraws $2.1 bln buyout offer for Evotec
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions